Philosophy 281Y

Bioethics

Winter 2004

 

 

1160 Bahen Centre                                                                                                      Professor Gopal Sreenivasan

MW 2-3:30                                                                                                                  215 Huron Street, Room 921

(416) 978-2824

                                                                                                                                gopal.sreenivasan@utoronto.ca

           

Reading Schedule

 

 

Distributive Justice and Health Care

 

Universality of Access   (continued)

 

January 5          Sreenivasan, “Paper.”  

 

J 7                    Buchanan, “The Right to a Decent Minimum of Health Care,” Philosophy & Public Affairs 13 (1984): 

                                    55-78.

 

J 12                  R. Dworkin, Sovereign Virtue (2000), ch. 8. 

 

J 14                  Reinhardt, “Reforming the Health Care System:  The Universal Dilemma,” American Journal of Law &

Medicine (1993):  21-36.

 

What should a health care system cover?

 

J 19                  Emanuel, Ends of Human Life (1991), pp. 97-124.

 

J 21                  Emanuel, pp. 124-154.

 

J 26                  Brock, “The problem of low benefit/high cost health care,” in his Life and Death (1993), pp. 325-355.

 

 

Rationing care

 

J 28                  Daniels, “Rationing fairly,” in his Justice and Justification (1996), ch. 15.

 

February 2       Film.  “Transplant Tourism.”

 

F 4                   Radcliffe-Richards et al., “The case for allowing kidney sales,” Lancet 351 (1998): 1950-52.

Friedlaender, “The right to sell or buy a kidney:  are we failing our patients?,Lancet 359 (2002): 971-73.

Delmonico et al., “Ethical Incentives – Not Payment – For Organ Donation,” N. Engl. J. Medicine 346

            (2002): 2002-2004.

Matas et al., “Nondirected Donation of Kidneys from Living Donors,” N. Engl. J. Med. 343 (2000):433-6.

Cronin et al., “Transplantation of Liver Grafts from Living Donors into Adults – Too Much, Too Soon,”

N. Engl. J. Medicine 344 (2001): 1633-35.

Segre et al., “Partial Liver Transplantation from Living Donors,” Cambridge Quarterly of Healthcare Ethics 4

            (1992): 305-25.

 

F 9                   Daniels, “The prudential life-span account of justice across generations,” in his Justice and Justification

                                    (1996), ch. 12.

 

F 11                 No class.

 

Spring Break.

 

F 23                 Callahan, Setting Limits (1987), ch. 5.

 

F 25                 Mid-term examination.  In class.

 

 

Research Ethics

 

March 1           Annas and Grodin (eds.) The Nazi Doctors and the Nuremburg Code (1992), ch. 5.

                        Beecher, “Ethics and Clinical Research,” N. Engl. J. Medicine 274 (1966): 1354-1360.

                        Brandt, “Racism and Research:  The case of the Tuskegee Syphilis Study,” Hastings Center Report 8

                                    (1978): 21-28.

 

M 3                  Emanuel et al., “What makes clinical research ethical?,JAMA 283 (2000): 2701-2711.

The Nuremburg Code.

                        The Declaration of Helsinki.

                        Tri-Council Policy Statement.  (FYI only).

 

M 8                  Katz, “Human Experimentation and Human Rights,” St. Louis University Law Journal 38 (1993):  7-20.

                        Schafer, “The Ethics of the Randomized Clinical Trial,” N. Engl. J. Medicine 307 (1982): 719-724.

Hellman and Hellman, “Of Mice But Not Men:  Problems of the Randomized Clinical Trial,”

            N. Engl. J. Medicine 324 (1991): 1585-89.

Bryant and Wolmark, “Letrozole after Tamoxifen for Breast Cancer—What Is the Price of Success?,

            N. Engl. J. Medicine 349 (2003): 1855-57.

 

 

M 10                Freedman, “Equipoise and the Ethics of Clinical Research,” N. Engl. J.Medicine 317 (1987): 141-145.

                        Passamani, “Clinical Trials – Are They Ethical?,N. Engl. J. Medicine 324 (1991): 1589-1592.

Truog, “Randomized Controlled Trials:  Lessons from ECMO,” Clinical Research 40 (1992):  519-527.

Second essay topics handed out.

 

M 15                Freedman, “Placebo-Controlled Trials and the Logic of Clinical Purpose,” IRB 12 (1990):  1-6.

                        Rothman and Michels, “The Continuing Unethical Use of PlaceboControls,” N. Engl. J. Medicine 331

                                    (1994): 394-398.

Temple and Ellenberg, “Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New

            Treatments:  Ethical and Scientific Issues” Annals of Internal Medicine 133 (2000):  455-463.

Miller and Emanuel, “The Ethics of Placebo-Controlled Trials – A Middle Ground,” N. Engl. J. Medicine

            345 (2001): 915-919.

 

M 17                Levine, “Informed Consent in Research and Practice,” Archives of Internal Medicine 143 (1983):1229-31.

                        Nelson and Merz, “Voluntariness of Consent for Research:  An Empirical and Conceptual Review,” Medical

                                    Care 40 (2002); V69-V80.

 

M 22                Appelbaum et al., “False Hopes and Best Data:  Consent to Research and the Therapeutic Misconception,” 

                                    Hastings Center Report (1987): 20-23.

                        Joffe et al., “Quality of informed consent in cancer clinical trials:  a cross-sectional survey,” Lancet 358

                                    (2001):  1772-77.

                        Sreenivasan, “Does informed consent to research require comprehension?,Lancet 362 (2003):  2016-18.

 

M 24               Love and Fost, “Ethical and Regulatory Challenges in a Randomized Controlled Trial of Adjuvant Treatment

                                    for Breast Cancer in Vietnam,” Journal of Investigative Medicine 45 (1997):  423-431.

Second essay due in class.

 

M 29                The Body Hunters.  Washington Post, December 17-22, 2000.

 

M 31                Angell, “The Ethics of Clinical Research in the Third World,” N. Engl. J. Medicine 337 (1997): 847-49.

Lurie and Wolfe, “Unethical Trials of Interventions to Reduce Perinatal Transmission of the HIV in

            Developing Countries,” N. Engl. J. Medicine 337 (1997): 853-856.

                        Phanuphak, “Ethical Issues in Studies in Thailand of the Vertical Transmission of HIV,” N. Engl. J. Medicine

                                    338 (1998): 834-835.

                        Bloom, “The Highest Attainable Standard:  Ethical Issues in AIDS Vaccines,  Science 279 (1998):186-8.

                        Crouch and Arras, “AZT Trials and Tribulations,  Hasting Center Report 28 (1998):  26-34.

                        Grady, “Science in the Service of Healing,” Hasting Center Report 28 (1998):  34-38.

Angell, “Investigators’ Responsibilities for Human Subjects in Developing Countries,” N. Engl. J. Medicine

            342 (2000): 967-969.

 

April 5              Glantz et al., “Research in Developing Countries:  Taking ‘Benefit Seriously,” Hasting Center Report 28

                                    (1998):  38-42.

                        Shapiro and Meslin, “Ethical Issues in the Design and Conduct of Clinical Trials in Developing Countries,”

                                    N. Engl. J. Medicine 345 (2001): 139-142.

El Setouhy et al., “Fair Benefits for Research in Developing Countries,” Science 298 (2002):  2133-34.

 

A 7                  No new reading. 

 

End of lectures.

 

Final examination in Spring examination period.

 

 

Readings

 

Course packages are available at the U of T Bookstore on College.  The final package will be available toward the end of February.

 

 

Assignments

 

There will be four examinations and two essays (2000 words) over the course of the whole year, an essay and two examinations in each term.  Each term there will be an in-class mid-term and an examination during the finals period.

 

The assignments will carry the following weights:

 

            Essays:                                                 20 % each.

            Fall mid-term:                                       5 %.

            Fall end-term examination:                    12 %.

            Spring mid-term:                                   10 %.

            Final examination:                                 33 %.

 

 

Office hours

 

Sreenivasan                  Mondays 4-5 and Tuesdays 2-3.  Room 921, 215 Huron Street.

I will also hold office hours by appointment.

 

TAs                              Office hours are posted after each graded assignment has been returned.

 

 

Late penalties

 

Essays submitted after the due date will be penalised one increment of a grade (e.g., from B to B-).  Essays submitted a week or more late will be penalised a further increment for each week late.

 

 

Plagiarism

 

Plagiarism is a serious academic offence.  It comes in various forms, all of which carry grave penalties.  If in doubt about what constitutes plagiarism, ask.  You should consult the Philosophy Department’s statement on plagiarism.

 

Students agree that by taking this course all required papers may be subject to submission for textual similarity review to Turnitin.com for the detection of plagiarism. All submitted papers will be included as source documents in the Turnitin.com reference database solely for the purpose of detecting plagiarism of such papers. The terms that apply to the University's use of the Turnitin.com service are described on the Turnitin.com web site.

 

 

Writing help

 

Help in writing is available from the Philosophy Department’s essay clinic.  You are also encouraged to consult the Department’s guide to writing a philosophy essay.

 

 

 

 

 

 

 

 

 

02 February 2004